INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2020

A systematic review of five clinical trials found sulforaphane use was positively correlated with improved behavior and cognitive function in ASD.

This systematic review assessed sulforaphane therapy as a treatment for individuals with autism spectrum disorder across multiple databases. All five included clinical trials reported a significant positive correlation between sulforaphane use and ASD behavior and cognitive function. The authors noted minimal side effects and concluded sulforaphane appears safe and effective for treating ASD.

Study type
Systematic review of clinical trials
Who was studied
Individuals with autism spectrum disorder (5 clinical trials)
What was measured
Behavior and cognitive function

THE PAPER

Sulforaphane treatment for autism spectrum disorder: A systematic review.

McGuinness G, Kim Y. EXCLI J, 2020.

PubMed 33013262 ↗DOI 10.17179/excli2020-2487 ↗

Brain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.